- Grand Challenges
- Network Sponsorship
- The Collective
- Thought Leadership
- Log In
Polypharmacy, the prescribing of multiple prescriptions to individual patients, is a growing problem in the United States, with devastating consequences, particularly for older adults. The Lown Institute reports that four in ten older adults take at least 5 medications per day while 20% take 10 or more. Adverse drug reactions have led to 35 million medical visits and 2 million hospital visits for U.S. older adults in the last decade. This “Medication Overload,” which has tripled over the past two decades, can be attributed to our prescribing culture, knowledge gaps, and fragmentation of care.
Join Aging2.0 Baltimore as we learn more about the statistics, impacts, and policy implications of “Medication Overload” with our speakers, Nicole Brandt (University of Maryland), Michelle Fritsch (Retirement Wellness Strategies), and Ilene Harris (IMPAQ International). During our networking reception, we will also meet several start-ups in the medication technology space.
Lamy Center on Drug Therapy and Aging at University of Maryland School of Pharmacy
Professor and Executive Director
Retirement Wellness Strategies
Vice President and Chief Research Officer
Dr. Nicole Brandt, PharmD, MBA, BCGP, BCPP, FASCP is the Executive Director of The Peter Lamy Center on Drug Therapy and Aging and Professor of Geriatric Pharmacotherapy in the Department of Pharmacy Practice and Science. After completing her Pre-Pharmacy/biochemistry at the State University of New York at Buffalo, Dr. Brandt obtained her doctor of pharmacy degree at the University of Maryland School of Pharmacy and her Master in Business Administration, focus in Healthcare Management with the Towson University/University of Baltimore. The focus of her work in geriatric pharmacotherapy has been to improve medication therapy and management for aging adults. She has actively led the development and refinement of Medication Therapy Management Programs for the Centers of Medicare & Medicaid, is a member of the National Committee for Quality Assurance’s Geriatric Measurement Advisory Panel and the Institute for Health Improvement. Her geriatric practice expertise has been recognized through certifications as a Geriatric Pharmacist, and Psychiatric Pharmacist, and fellowship status within the American Society of Consultant Pharmacists (ASCP). Nicole is finishing her presidency term for ASCP where she is currently Chair of the Board.
Michelle Fritsch, Pharm.D., BCGP, BCACP is a board certified geriatric clinical pharmacist with a passion for healthy aging and education. She is a specialist in medication use in people over 60. She is founder of Retirement Wellness Strategies and Meds MASH, LLC. She works with a broad definition of health – physical, mental, emotional, spiritual, and social.
She is a frequent speaker, lately on topics of safe medication use, falls prevention, medical cannabis, addiction, opioid use, coordination of healthcare, retirement readiness, and medication role in healthy aging.
She is a Purdue graduate with post-doctoral training in Madison, Wisconsin. She has been a professor teaching pharmacists, physicians, nurses, physician assistants, and physical therapists since 1992.
Dr. Harris (Ph.D., Epidemiology, and PharmD, University of Maryland, Baltimore) has more than 30 years of experience in geriatrics, medication use and quality, medication adherence, long-term care, dementia, traumatic brain injury and drug policy and program evaluation.
Dr. Harris’ research focuses on assessment of quality and appropriateness of care in long term care and community settings, care transitions into and out of nursing homes, and development of medication quality measures. She currently serves as the Project Director on a contract to evaluate the Maryland Multipayer Patient Centered Medical Home demonstration. She is Principal Investigator on a Cooperative Agreement with the US Food and Drug Administration’s Office of Generic Drugs to examine the utilization and switchback rates of brand versus generic drug products.
Prior to joining IMPAQ, she was on the faculty of the University of Maryland, Baltimore, School of Pharmacy from 1983 to 2013. While there, she served as Chair of the Department of Pharmaceutical Health Services Research and as Associate Dean for Research and Graduate Education.
Green & Healthy Homes Initiative
Program Design Specialist
Disclaimers: By registering for, or attending, this event, you are agreeing to the following: Photographs may be taken at the event and appear on social media. You are authorizing Aging2.0 to use your image, likeness and / or name on social media such as Facebook, Twitter, the Aging2.0 blog or other marketing materials in connection with the event. The organizers of this event, Aging2.0, and any of their employees, volunteers, members and representatives are not responsible for any injury, loss or damage of any kind sustained by any person while participating in this event.